Join the 200th Anniversary Celebration

Original Article

Pulmonary Epithelial Sodium-Channel Dysfunction and Excess Airway Liquid in Pseudohypoaldosteronism

Eitan Kerem, M.D., Tzvy Bistritzer, M.D., Aaron Hanukoglu, M.D., Thomas Hofmann, M.D., Zhaoqing Zhou, Ph.D., William Bennett, Ph.D., Eithne MacLaughlin, M.D., Pierre Barker, M.D., Martin Nash, M.D., Lynne Quittell, M.D., Richard Boucher, M.D., Vera Homolya, M.S., Bruce Keenan, M.D., and Michael R. Knowles, M.D.

N Engl J Med 1999; 341:156-162July 15, 1999

Abstract

Background

Active sodium absorption is the dominant mechanism of ion transport in airway epithelium, but its role in pulmonary physiology and airway host defense is unknown. To address this question, we studied the function of airway epithelial cells and determined the frequency of pulmonary symptoms in patients with systemic pseudohypoaldosteronism, a salt-losing disorder caused by loss-of-function mutations in the genes for the epithelial sodium channel.

Methods

In nine patients 1.5 to 22 years of age who had systemic pseudohypoaldosteronism, we tested for mutations in the genes for the epithelial sodium channel, estimated the rate of sodium transport in the airway, determined the volume and ion composition of airway surface liquid, reviewed clinical features, collected laboratory data pertinent to pulmonary function, and, in three adults, measured mucociliary clearance.

Results

The patients with systemic pseudohypoaldosteronism had loss-of-function mutations in the genes for the epithelial sodium-channel subunits, no sodium absorption from airway surfaces, and a volume of airway surface liquid that was more than twice the normal value. The mean (±SE) mucociliary transport rate was higher in the 3 adult patients than in 12 normal subjects (2.0±0.7 vs. 0.5±0.3 percent per minute, P=0.009). Young patients (those five years of age or less) all had recurrent episodes of chest congestion, coughing, and wheezing, but no airway infections with Staphylococcus aureus or Pseudomonas aeruginosa. Older patients (those more than five years of age) had less frequent respiratory symptoms.

Conclusions

Patients with systemic pseudohypoaldosteronism fail to absorb liquid from airway surfaces; the result is an increased volume of liquid in the airways. These results demonstrate that sodium transport has a role in regulating the volume of liquid on airway surfaces.

Media in This Article

Figure 4Posterior Gamma-Camera Radionuclide Images of Whole-Lung Clearance in a Normal Subject and a Patient with Systemic Pseudohypoaldosteronism Immediately after Inhalation of Technetium-99m–Labeled Iron Oxide Particles and 10, 20, and 30 Minutes Later.
Figure 2Mean (±SE) Volume for Weight, Ionic Composition, and Estimated Osmolarity [2([NA+] + [K+])] of Nasal Surface Liquid Recovered from Eight Normal Subjects (Open Bars), Eight Patients with Systemic Pseudohypoaldosteronism (Solid Bars), and Three Patients with Renal Pseudohypoaldosteronism (Hatched Bars).
Article

Pseudohypoaldosteronism is a rare syndrome characterized by defective sodium transport in the distal nephron and renal salt wasting despite high serum aldosterone concentrations. Two clinically distinct forms of pseudohypoaldosteronism have been described.1 The systemic form is characterized by salt loss from multiple organs, including the kidneys, colon, salivary glands, and sweat ducts. It is inherited as an autosomal recessive trait and is caused by loss-of-function mutations in the genes for an epithelial sodium channel in those tissues.2,3 The renal form is characterized by salt loss from the kidneys. It is inherited as an autosomal dominant trait and is caused by mutations in the mineralocorticoid-receptor gene.4 Both forms of pseudohypoaldosteronism present in the first week of life with dehydration, hyponatremia, and hyperkalemia. Children with systemic, but not renal, pseudohypoaldosteronism have frequent lower respiratory tract illnesses of unknown cause.5,6

It is difficult to predict the phenotype and pathophysiology of lung disease in patients in whom airway epithelial sodium transport may be absent. Active sodium absorption is the dominant pathway of ion transport in airway epithelium, but the relations among sodium transport, the volume and composition of airway surface liquid, and the efficiency of mucociliary clearance have not been clearly defined.7-12 If sodium-channel mutations associated with systemic pseudohypoaldosteronism cause a loss of airway sodium transport, the study of patients with these mutations would provide an opportunity to determine the role of sodium transport in the physiology of airway surface liquid and, possibly, defense against lung disease. Therefore, we studied airway epithelial sodium transport and the volume and composition of airway surface liquid in patients with pseudohypoaldosteronism and characterized their pulmonary syndrome.

Methods

Subjects

We studied nine patients from eight families with systemic pseudohypoaldosteronism (Table 1Table 1Demographic Characteristics, Sweat and Salivary Electrolyte Concentrations, and Genotypes of Patients with Systemic Pseudohypoaldosteronism.) and four patients from three families with renal pseudohypoaldosteronism (three boys and one girl 6 to 10 years of age). The diagnosis of pseudohypoaldosteronism was based on severe renal salt wasting in early infancy in association with hyponatremia, hyperkalemia, metabolic acidosis, hyperreninemia (plasma renin activity of more than 10 ng per milliliter per hour [2.8 ng per liter per second]), and hyperaldosteronism (serum aldosterone concentrations greater than 100 ng per deciliter [2700 pmol per liter]), but who otherwise had normal adrenal function. The patients with systemic pseudohypoaldosteronism, but not those with renal pseudohypoaldosteronism, had high sodium and chloride concentrations in the saliva and sweat (Table 1). Gastroesophageal reflux had been diagnosed in six of the children 1.5 to 6 years of age with pseudohypoaldosteronism13; two had undergone Nissen fundoplication, with no change in respiratory symptoms. Two of the patients (Patients 6 and 9) have previously been described.2,14 The study was approved by the human-rights committees at all participating centers, and informed consent was obtained from all patients or their parents.

Clinical Evaluation

In all the patients we evaluated respiratory symptoms and performed a physical examination. In most patients, we performed chest and sinus radiography and microbiologic examination of sputum or bronchial-lavage fluid; determined atopic status by skin-prick testing15; determined the clinical or spirometric response to an inhaled β-agonist drug or a glucocorticoid; and performed spirometry. In some patients, we measured lung volumes by body plethysmography or functional residual capacity by the nitrogen-washout technique, the diffusing capacity of the lung by the carbon monoxide technique, and bronchial reactivity by methacholine challenge.16-19

Detection of Mutations

Genomic DNA isolated from peripheral leukocytes or messenger RNA isolated from nasal epithelium was tested for mutations in the genes encoding the α, β, and γ subunits of the epithelial sodium channel by single-strand conformation polymorphism analysis with the use of products amplified by the polymerase chain reaction2,20 and by direct-sequencing analysis.

Sodium Transport in the Airway Epithelium

Rates of sodium transport in nasal and bronchial epithelium were estimated by measuring the basal transepithelial voltage and determining the reduction in voltage during luminal perfusion of amiloride (10–4 M) or sodium-free Ringer's solution.21,22

Volume and Composition of Airway Surface Liquid

Nasal and bronchial surface liquids were collected by the filter-paper technique.23 In two patients with systemic pseudohypoaldosteronism, approximately 3 ml of clear liquid was aspirated from bronchial surfaces with a transbronchoscopic catheter. Ion composition, volume, and osmolarity [2([Na+] + [K+])] were estimated as described previously.23

Bronchoscopy

Three patients underwent diagnostic bronchoscopy, and research studies were performed during the procedure. Two patients (both 6 years of age) were sedated with parenteral midazolam, fentanyl, and atropine, and one patient (18 months of age) was sedated with parenteral propofol. Lidocaine (2 percent) was applied only to the pharynx and vocal cords. After the collection of surface liquid, a 3.5-mm bronchoscope (model 20PD or 3C20, Olympus, Lake Success, N.Y.) was wedged in the right lower lobe for bronchoalveolar lavage (three aliquots of 1 ml of normal saline per kilogram of body weight). The lavage fluid was cultured for quantitative determination of bacteria24 and was examined for cells and protein.23

Mucociliary Clearance

In three adults with systemic pseudohypoaldosteronism, clearance rates of technetium-99m–labeled iron oxide particles (median diameter, 4.5 μm) from the lungs were determined by gamma-camera analysis.25 The initial deposition patterns were determined, and activity in the right lung was monitored for two hours. Clearance rates (percentage cleared per minute) were calculated from a best-fit regression of retained activity against time and compared with values in normal adults.25

Statistical Analysis

Values are expressed as means ±SE. Bioelectric and electrolyte values for each nostril were averaged to give a value for each subject. The differences between study groups were compared by nonpaired t-tests. The difference between the mucociliary clearance rates in the normal subjects and in the patients with systemic pseudohypoaldosteronism was evaluated by the Kruskal–Wallis test.26

Results

Course of Respiratory Disease

All patients with systemic pseudohypoaldosteronism had salt wasting and electrolyte disturbances 24 to 72 hours after birth, but none had respiratory symptoms. Within weeks or months after birth, all patients had respiratory illnesses (three to six per year) characterized by chest congestion, cough, and tachypnea and often associated with fever, wheezing and crackles, and mild leukocytosis. Blood cultures were negative, and bacterial causes were not identified. In patients more than five years of age, respiratory illnesses were less severe and less frequent. Skin tests were negative for common allergens. No patient had digital clubbing, chronic sinusitis, clinical or radiographic evidence of bronchiectasis, or airway infection with Staphylococcus aureus or Pseudomonas aeruginosa.

Genotypes in Patients with Systemic Pseudohypoaldosteronism

Three patients, each born to consanguineous parents, were homozygous for a stop mutation (Arg508Stop) resulting from a cytosine-to-thymidine mutation at nucleotide 1621 of the gene for the α subunit of the sodium channel (Table 1). One patient had two frame-shift mutations in the gene for the α subunit (deletion of adenine and cytosine at nucleotide 604 and deletion of cytosine at nucleotide 1404), one patient had two frame-shift mutations in the gene for the β subunit (insertion of adenine at nucleotide 647 and deletion of cytosine at nucleotide 915), and one patient had one stop mutation (Arg56Stop, resulting from a cytosine-to-thymidine mutation at nucleotide 256) and one in-frame deletion (deletion of exons 3 and 4) in the gene for the α subunit.

Bioelectric Measurements in the Airway

Electrogenic nasal epithelial sodium transport was absent in patients with systemic pseudohypoaldosteronism (Figure 1Figure 1Mean (±SE) Bioelectric Indexes of Nasal Epithelial Sodium Transport in 33 Normal Subjects (Open Bars), 9 Patients with Systemic Pseudohypoaldosteronism (Solid Bars), and 3 Patients with Renal Pseudohypoaldosteronism (Hatched Bars).). The basal transepithelial potential difference was only about 35 percent of the normal value, and the potential difference was not reduced by perfusing the lumen with amiloride, a sodium-channel inhibitor (mean [±SE] change, –0.9±0.4 mV), or with sodium-free Ringer's solution (mean [±SE] change in three patients, +2.7±1.2 mV).22 The bronchial potential difference measured in one patient (Patient 1) was much lower (–2 mV) than that in normal subjects (approximately –20 mV) and was not reduced by amiloride.27

Volume and Composition of Nasal Surface Liquid

The volume of nasal surface liquid obtained from the patients with systemic pseudohypoaldosteronism was more than twice that obtained from normal subjects (Figure 2Figure 2Mean (±SE) Volume for Weight, Ionic Composition, and Estimated Osmolarity [2([NA+] + [K+])] of Nasal Surface Liquid Recovered from Eight Normal Subjects (Open Bars), Eight Patients with Systemic Pseudohypoaldosteronism (Solid Bars), and Three Patients with Renal Pseudohypoaldosteronism (Hatched Bars).). The concentration of sodium in the surface liquid from patients with systemic pseudohypoaldosteronism was higher and that of potassium was lower than in the samples from normal subjects or patients with renal pseudohypoaldosteronism (Figure 2). The surface liquid was approximately isotonic (about 305 mmol per liter) with plasma. Children with systemic pseudohypoaldosteronism had a chronic nasal drip of clear liquid that caused irritation of the philtrum area (Figure 3AFigure 3Excess Airway Liquid in Patient 3, a Six-Year-Old Boy with Systemic Pseudohypoaldosteronism.).

Bronchoscopy

The three patients who underwent diagnostic bronchoscopy (Patients 1, 3, and 4) had a large volume of bronchial surface liquid (Figure 3B). The protein concentration of the liquid was 24 and 40 mg per deciliter (<1 percent of the serum protein concentration) in the two patients in whom it was measured (Patients 3 and 4, respectively), and the mean osmolality was 298 mOsm per kilogram. The concentration of sodium in the liquid was high (141±10 mmol per liter) and that of potassium was low (7.9±3.5 mmol per liter) in comparison with that in normal bronchial surface liquid.23

Microbiologic Examination

There were inflammatory cells and bacteria in the bronchial-lavage fluid from the three patients who underwent bronchoscopy. The proportion of neutrophils ranged from 10 to 79 percent of the recovered cells. One patient (Patient 1) had a large amount of cloudy liquid in the proximal airways, from which Moraxella catarrhalis and Haemophilus influenzae were cultured (100,000 and 40,000 colony-forming units per milliliter, respectively). In two patients (Patients 3 and 4) in whom the liquid was clear, Streptococcus pneumoniae was cultured (50,000 and 100,000 colony-forming units per milliliter, respectively). The five older patients (6 to 22 years of age) produced small sputum samples that contained only normal flora.

Pulmonary-Function Tests

The results of spirometry were normal in seven patients who were tested when they were not acutely ill. Of the four children tested, three (Patients 3, 4, and 6) had mild air trapping (increased functional residual capacity or residual volume), whereas the three adults did not. Methacholine-challenge tests were positive in four of the five patients tested (Patients 3, 4, 6, and 9). However, only two of seven patients treated with bronchodilators had improvement on spirometric measurements or clinical benefit, and only one had a clinical response to treatment with inhaled glucocorticoids.

Radiographic Studies

Patients six years of age or less had hyperinflation, apparent bronchial thickening, and intermittent segmental atelectasis, but no evidence of bronchiectasis or lobar consolidation. Chest radiographs in the older patients were normal. Sinus radiographs were normal in seven of eight patients.

Mucociliary Clearance

There was rapid transport of radiotracer in the three patients with systemic pseudohypoaldosteronism in whom we tested mucociliary clearance (Figure 4Figure 4Posterior Gamma-Camera Radionuclide Images of Whole-Lung Clearance in a Normal Subject and a Patient with Systemic Pseudohypoaldosteronism Immediately after Inhalation of Technetium-99m–Labeled Iron Oxide Particles and 10, 20, and 30 Minutes Later.). The mean clearance rate in the 3 patients was more rapid than in the 12 normal subjects (2.0±0.7 vs. 0.5±0.3 percent per minute for the initial 20 minutes, P=0.009).25

Discussion

The patients with systemic pseudohypoaldosteronism had the typical clinical features of the disorder, with severe neonatal salt wasting, hyponatremia, hyperkalemia, metabolic acidosis, high serum aldosterone concentrations, and recurrent respiratory illness in the first years of life.1-3,5 These patients required high doses of salt replacement into adulthood. These clinical features contrasted with those of the patients with renal pseudohypoaldosteronism, in whom the disease was limited to the kidney and who did not require dietary salt supplementation after the age of five years.

We identified frame-shift, deletion, or stop mutations in the genes for the subunits of the epithelial sodium channel on both alleles in six of the nine patients with systemic pseudohypoaldosteronism (Table 1). These mutations cause systemic pseudohypoaldosteronism, probably by eliminating sodium-channel function.2,3,28 The three patients with no identified mutations may have intronic or promoter mutations or mutations in other proteins responsible for the assembly or function of sodium channels.

The patients with systemic pseudohypoaldosteronism had a total absence of electrogenic sodium transport in the upper and lower airways (Figure 1). The chief physiologic consequence of defective sodium transport was an increase in the volume of airway surface liquid. The presence of excessive liquid on airway surfaces was associated with a distinct respiratory syndrome. Children had persistent rhinorrhea of clear liquid, with chronically chapped upper lips. In the first years of life, these children also had recurrent respiratory illnesses characterized by congestion, tachypnea, wheezing, and frequently fever. Although aspects of these illnesses were suggestive of asthma, only two of the patients had high serum IgE concentrations (Patients 7 and 9), and they did not benefit from therapy with aerosolized β-adrenergic agonists or glucocorticoids.

We speculate that the pulmonary syndrome in patients with systemic pseudohypoaldosteronism is caused by an excessive volume of surface liquid that narrows airway lumens and dilutes surface-active materials that stabilize small airways,29,30 predisposing the patients to wheezing and airway infections early in life. As in viral bronchiolitis, airway narrowing due to intraluminal liquid may be more prominent in infancy and early childhood when the airway diameter is small. This speculation is compatible with the positive results of methacholine challenge in four of the five patients tested; such results can be due to a decreased airway caliber in patients who do not have atopy.31,32

The failure to absorb liquid as it moves up the converging surfaces of the airways predicts that sufficient liquid will accumulate on proximal airways to produce airflow obstruction — that is, “intrapulmonary drowning.”7 To compensate for the failure to absorb liquid from airway surfaces in patients with systemic pseudohypoaldosteronism, the rate of mucociliary clearance increases to remove some of the excess volume from airway surfaces. The mechanism of the increased rate of mucociliary clearance in these patients is unclear. The efficiency of mucociliary clearance is thought to be dependent on contact of ciliary tips with the inner surface of a layer of mucus. Our data from patients with systemic pseudohypoaldosteronism suggest that an expansion of the volume of airway surface liquid does not “float” mucus off the tips of cilia and slow mucociliary clearance. It is more likely that the excess volume is added to the mucous layer, improving its biorheologic properties and clearance rates.7,33

The functional defects in the airway epithelium of patients with systemic pseudohypoaldosteronism provide insights into the relations among epithelial sodium transport, the volume and composition of airway surface liquid, and the pathogenesis of airway disease, including cystic fibrosis. Some have suggested that the function of sodium transport in the airway epithelium is to generate hypotonic (i.e., low sodium and low chloride) airway surface liquid that promotes the antimicrobial activities of salt-sensitive defensins.10,11 According to this hypothesis, chronic bacterial airway infections in patients with cystic fibrosis reflect the inability of the airway epithelium to lower the concentration of sodium and chloride in airway surface liquid, thereby inactivating defensins and promoting infection. Others have suggested that sodium transport normally regulates the volume of an isotonic airway surface liquid, and that this regulation is important for mucus clearance.23,27,33 According to this hypothesis, sodium and volume absorption is increased in cystic fibrosis, mucus transport is abolished, and chronic infection follows.33 The data from the patients with systemic pseudohypoaldosteronism argue for the latter hypothesis: sodium transport is linked to regulation of the volume of airway surface liquid, not to its tonicity, and chronic bacterial airway infection is not associated with isotonic airway surface liquid if mucus clearance is preserved.

In summary, studies of patients with systemic pseudohypoaldosteronism demonstrate the linkage between sodium transport and the volume of airway surface liquid, rather than its tonicity, in lung physiology. The pulmonary disease in young children with systemic pseudohypoaldosteronism represents a novel form of airway disease associated with the excess volume of airway surface liquid resulting from defective sodium-dependent liquid absorption. An increase in the rate of clearance of liquid from airway surfaces by mucociliary transport appears to compensate, in part, for the failure to absorb liquid transepithelially.

Supported by grants from the Cystic Fibrosis Foundation (CFF RDP R026), the National Heart, Lung, and Blood Institute (P01 HL34322), and the National Institutes of Health (RR00046).

We are indebted to Michael Wilshanski, M.D., Joe Robinson, M.S., Carla Foy, B.S., Kirby Zeman, Ph.D., John Gatzy, Ph.D., and Robert E. Wood, M.D., Ph.D., for assisting in some of the studies; to William Brandenburger, M.D., Francine R. Kaufman, M.D., Michael Schechter, M.D., and Beth Steindel, M.D., for assisting in the care of the patients; to George Chrousos, M.D., Larry Kirschner, M.D., and Maria New, M.D., for referral of patients; and to Lisa Brown and Beth Godwin for editorial assistance.

Source Information

From the Pediatric Respiratory Medicine and Cystic Fibrosis Center, Shaare Zedek Medical Center, Hebrew University Medical School, Jerusalem, Israel (E.K.); the Department of Pediatrics, Assaf Harofeh Medical Center, Zerifin, Israel (T.B.); the Department of Pediatrics, Wolfson Medical Center, Holon, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel (A.H.); Justus Liebig Universität Kinderklinik, Pädiatrische Pneumonologie, Giessen, Germany (T.H.); the Cystic Fibrosis–Pulmonary Research and Treatment Center (Z.Z., P.B., R.B., M.R.K.) and the Center for Environmental Medicine (W.B.), University of North Carolina at Chapel Hill; the Division of Pediatric Pulmonology, Childrens Hospital Los Angeles and the University of Southern California, Los Angeles (E.M.); and the Pediatric Nephrology Division (M.N.) and Pediatric Pulmonary Division (L.Q.), Columbia–Presbyterian Medical Center, New York.

Address reprint requests to Dr. Knowles at the Cystic Fibrosis–Pulmonary Research and Treatment Center, 7011 Thurston-Bowles Bldg., CB 7248, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7248, or at .

Other authors were Vera Homolya, M.S. (University of North Carolina, Chapel Hill), and Bruce Keenan, M.D. (Department of Pediatrics, University of Texas, Galveston).

References

References

  1. 1

    Hanukoglu A. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J Clin Endocrinol Metab 1991;73:936-944
    CrossRef | Web of Science | Medline

  2. 2

    Chang SS, Grunder S, Hanukoglu A, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type I. Nat Genet 1996;12:248-253
    CrossRef | Web of Science | Medline

  3. 3

    Strautnieks SS, Thompson RJ, Gardiner RM, Chung E. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat Genet 1996;13:248-250
    CrossRef | Web of Science | Medline

  4. 4

    Geller DS, Rodriquez-Soriano J, Vallo Boado A, et al. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 1998;19:279-281
    CrossRef | Web of Science | Medline

  5. 5

    Hanukoglu A, Bistritzer T, Rakover Y, Mandelberg A. Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J Pediatr 1994;125:752-755
    CrossRef | Web of Science | Medline

  6. 6

    Marthinsen L, Kornfalt R, Aili M, Andersson D, Westgren U, Schaedel C. Recurrent Pseudomonas bronchopneumonia and other symptoms as in cystic fibrosis in a child with type I pseudohypoaldosteronism. Acta Paediatr 1998;87:472-474
    CrossRef | Web of Science | Medline

  7. 7

    Kilburn KH. A hypothesis for pulmonary clearance and its implications. Am Rev Respir Dis 1968;98:449-463
    Web of Science | Medline

  8. 8

    Boucher RC. Human airway ion transport. Am J Respir Crit Care Med 1994;150:271-281
    Web of Science | Medline

  9. 9

    Wanner A, Salathe M, O'Riordan TG. Mucociliary clearance in the airways. Am J Respir Crit Care Med 1996;154:1868-1902
    Web of Science | Medline

  10. 10

    Quinton PM. Viscosity versus composition in airway pathology. Am J Respir Crit Care Med 1994;149:6-7
    Web of Science | Medline

  11. 11

    Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996;85:229-236[Erratum, Cell 1996;87:355a.]
    CrossRef | Web of Science | Medline

  12. 12

    Wine JJ. The genesis of cystic fibrosis lung disease. J Clin Invest 1999;103:309-312
    CrossRef | Web of Science | Medline

  13. 13

    Working Group of the European Society of Pediatric Gastroenterology and Nutrition. A standardized protocol for the methodology of esophageal pH monitoring and interpretation of the data for the diagnosis of gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1992;14:467-471
    CrossRef | Web of Science | Medline

  14. 14

    Oberfield SE, Levine LS, Carey RM, Bejar R, New MI. Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab 1979;48:228-234
    CrossRef | Web of Science | Medline

  15. 15

    Skin tests used in type I allergy testing position paper: Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 1989;44:Suppl 10:1-59
    CrossRef | Web of Science | Medline

  16. 16

    Hargreave FE, Ryan G, Thomson NC, et al. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981;68:347-355
    CrossRef | Web of Science | Medline

  17. 17

    Avital A, Bar-Yishay E, Springer C, Godfrey S. Bronchial provocation tests in young children using tracheal auscultation. J Pediatr 1988;112:591-594
    CrossRef | Web of Science | Medline

  18. 18

    Lodrup-Carlsen KC, Carlsen KH. Lung function in awake healthy infants: the first five days of life. Eur Respir J 1993;6:1496-1500
    Web of Science | Medline

  19. 19

    Gerhardt T, Hehre D, Bancalari E, Watson H. A simple method for measuring functional residual capacity by N2 washout in small animals and newborn infants. Pediatr Res 1985;19:1165-1169
    CrossRef | Web of Science | Medline

  20. 20

    Highsmith WE, Burch LH, Zhou A, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994;331:974-980
    Full Text | Web of Science | Medline

  21. 21

    Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995;6:445-455
    CrossRef | Web of Science | Medline

  22. 22

    Knowles M, Gatzy J, Boucher R. Relative ion permeability of normal and cystic fibrosis nasal epithelium. J Clin Invest 1983;71:1410-1417
    CrossRef | Web of Science | Medline

  23. 23

    Knowles MR, Robinson JM, Wood RE, et al. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Invest 1997;100:2588-2595[Erratum, J Clin Invest 1998;101:285.]
    CrossRef | Web of Science | Medline

  24. 24

    Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991;4:35-51
    Web of Science | Medline

  25. 25

    Olivier KN, Bennett WD, Hohneker KW, et al. Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults. Am J Respir Crit Care Med 1996;154:217-223
    Web of Science | Medline

  26. 26

    Zar JH. Biostatistical analysis. 3rd ed. Upper Saddle River, N.J.: Prentice-Hall, 1996.

  27. 27

    Boucher RC. Human airway ion transport. Am J Respir Crit Care Med 1994;150:581-593
    Web of Science | Medline

  28. 28

    Li X-J, Xu R-H, Guggino WB, Snyder SH. Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore. Mol Pharmacol 1995;47:1133-1140
    Web of Science | Medline

  29. 29

    Clark JC, Weaver TE, Iwamoto HS, et al. Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice. Am J Respir Cell Mol Biol 1997;16:46-52
    Web of Science | Medline

  30. 30

    Yager D, Butler JP, Bastacky J, Israel E, Smith G, Drazen JM. Amplification of airway constriction due to liquid filling of airway interstices. J Appl Physiol 1989;66:2873-2884
    CrossRef | Web of Science | Medline

  31. 31

    Mitchell I, Corey M, Woenne R, Krastins IRB, Levinson H. Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr 1978;93:744-748
    CrossRef | Web of Science | Medline

  32. 32

    Sanchez I, Powell RE, Pasterkamp H. Wheezing and airflow obstruction during methacholine challenge in children with cystic fibrosis and in normal children. Am Rev Respir Dis 1993;147:705-709
    Web of Science | Medline

  33. 33

    Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998;95:1005-1015
    CrossRef | Web of Science | Medline

Citing Articles (71)

Citing Articles

  1. 1

    Daniella Magen, Israel Zelikovic. 2012. Hereditary Tubular Disorders of Mineral Handling. , 727-770.
    CrossRef

  2. 2

    Yehoshua Enuka, Israel Hanukoglu, Oded Edelheit, Hananya Vaknine, Aaron Hanukoglu. (2011) Epithelial sodium channels (ENaC) are uniformly distributed on motile cilia in the oviduct and the respiratory airways. Histochemistry and Cell Biology
    CrossRef

  3. 3

    S Huppmann, E Lankes, D Schnabel, C Bührer. (2011) Unimpaired postnatal respiratory adaptation in a preterm human infant with a homozygous ENaC-α unit loss-of-function mutation. Journal of Perinatology 31:12, 802-803
    CrossRef

  4. 4

    Christiane De Boeck, Harry Cuppens. (2011) Ion channel regulators for the treatment of cystic fibrosis. Therapy 8:6, 661-670
    CrossRef

  5. 5

    William J. Wilkinson, Audra R. Benjamin, Ian Proost, Maria C. Orogo-Wenn, Yasuo Yamazaki, Olivier Staub, Takashi Morita, Dirk Adriaensen, Daniela Riccardi, Dafydd V. Walters, Paul J. Kemp. (2011) Alveolar epithelial CNGA1 channels mediate cGMP-stimulated, amiloride-insensitive, lung liquid absorption. Pflügers Archiv - European Journal of Physiology 462:2, 267-279
    CrossRef

  6. 6

    Michael Stowasser, Eduardo Pimenta, Richard D. Gordon. (2011) Familial or Genetic Primary Aldosteronism and Gordon Syndrome. Endocrinology & Metabolism Clinics of North America 40:2, 343-368
    CrossRef

  7. 7

    Maria-Christina Zennaro, Edwige-Ludiwyne Hubert, Fábio L. Fernandes-Rosa. (2011) Aldosterone resistance: Structural and functional considerations and new perspectives. Molecular and Cellular Endocrinology
    CrossRef

  8. 8

    C Katz, L Bentur, N Elias. (2011) Clinical implication of lung fluid balance in the perinatal period. Journal of Perinatology 31:4, 230-235
    CrossRef

  9. 9

    Carlos E. Milla, Jacquelyn Zirbes. (2011) Pulmonary Complications of Endocrine and Metabolic Disorders. Paediatric Respiratory Reviews
    CrossRef

  10. 10

    Jinho Jung, Jae-Gu Cho, Sung-Won Chae, Heung-Man Lee, Soon-Jae Hwang, Jeong-Soo Woo. (2011) Epithelial Na+ channel (ENaC) expression in obstructive sialadenitis of the submandibular gland. Archives of Oral Biology 56:2, 121-126
    CrossRef

  11. 11

    Jeng-Haur Chen, David A. Stoltz, Philip H. Karp, Sarah E. Ernst, Alejandro A. Pezzulo, Thomas O. Moninger, Michael V. Rector, Leah R. Reznikov, Janice L. Launspach, Kathryn Chaloner, Joseph Zabner, Michael J. Welsh. (2010) Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia. Cell 143:6, 911-923
    CrossRef

  12. 12

    Madhuri Bhuvanagiri, Anna M. Schlitter, Matthias W. Hentze, Andreas E. Kulozik. (2010) NMD: RNA biology meets human genetic medicine. Biochemical Journal 430:3, 365-377
    CrossRef

  13. 13

    Weifeng Song, Shipeng Wei, Sadis Matalon. (2010) Inhibition of epithelial sodium channels by respiratory syncytial virus in vitro and in vivo. Annals of the New York Academy of Sciences 1203:1, 79-84
    CrossRef

  14. 14

    David S. Geller. (2010) Clinical Evaluation of Mendelian Hypertensive and Hypotensive Disorders. Seminars in Nephrology 30:4, 387-394
    CrossRef

  15. 15

    Erol A. Gaillard, Pradeep Kota, Martina Gentzsch, Nikolay V. Dokholyan, M. Jackson Stutts, Robert Tarran. (2010) Regulation of the epithelial Na+ channel and airway surface liquid volume by serine proteases. Pflügers Archiv - European Journal of Physiology 460:1, 1-17
    CrossRef

  16. 16

    Derek Paisley, Martin Gosling, Henry Danahay. (2010) Regulation of airway mucosal hydration. Expert Review of Clinical Pharmacology 3:3, 361-369
    CrossRef

  17. 17

    Robert Rauh, Alexei Diakov, Anja Tzschoppe, Judit Korbmacher, Abul Kalam Azad, Harry Cuppens, Jean-Jaques Cassiman, Jörg Dötsch, Heinrich Sticht, Christoph Korbmacher. (2010) A mutation of the epithelial sodium channel associated with atypical cystic fibrosis increases channel open probability and reduces Na+ self inhibition. The Journal of Physiology 588:8, 1211-1225
    CrossRef

  18. 18

    Oded Edelheit, Israel Hanukoglu, Yafit Shriki, Matanel Tfilin, Nathan Dascal, David Gillis, Aaron Hanukoglu. (2010) Truncated beta epithelial sodium channel (ENaC) subunits responsible for multi-system pseudohypoaldosteronism support partial activity of ENaC. The Journal of Steroid Biochemistry and Molecular Biology 119:1-2, 84-88
    CrossRef

  19. 19

    Constantine A. Stratakis. 2010. Genetic Conditions Associated with Congenital Adrenocortical Insufficiency or Glucocorticoid and/or Mineralocorticoid Resistance. , 193-203.
    CrossRef

  20. 20

    Yanhong Li, Marie-Odile Marcoux, Martine Gineste, Mireille Vanpee, Marina Zelenina, Charlotte Casper. (2009) Expression of water and ion transporters in tracheal aspirates from neonates with respiratory distress. Acta Paediatrica 98:11, 1729-1737
    CrossRef

  21. 21

    Jae-Jun Song, Seong Keun Kown, Eo-Jin Kim, Yung-Seop Lee, Bo-Yeon Kim, Sung-Won Chae. (2009) Mucosal expression of ENaC and AQP in experimental otitis media induced by Eustachian tube obstruction. International Journal of Pediatric Otorhinolaryngology 73:11, 1589-1593
    CrossRef

  22. 22

    Abul Kalam Azad, Robert Rauh, François Vermeulen, Martine Jaspers, Judit Korbmacher, Brigitte Boissier, Laurence Bassinet, Yann Fichou, Marie des Georges, Frauke Stanke, Kris De Boeck, Lieven Dupont, Miroslava BalasÌcÌáková, Lena Hjelte, Patrick Lebecque, Dragica Radojkovic, Carlo Castellani, Marianne Schwartz, Manfred Stuhrmann, Martin Schwarz, Veronika Skalicka, Isabelle de Monestrol, Emmanuelle Girodon, Claude Férec, Mireille Claustres, Burkhard Tümmler, Jean-Jacques Cassiman, Christoph Korbmacher, Harry Cuppens. (2009) Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Human Mutation 30:7, 1093-1103
    CrossRef

  23. 23

    S Ben-Shachar, M Khajavi, MA Withers, CA Shaw, H van Bokhoven, HG Brunner, JR Lupski. (2009) Dominant versus recessive traits conveyed by allelic mutations - to what extent is nonsense-mediated decay involved?. Clinical Genetics 75:4, 394-400
    CrossRef

  24. 24

    Bahareh Schweiger, Margaret W Moriarty, Melissa A Cadnapaphornchai. (2009) Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1. Current Opinion in Pediatrics 21:2, 269-271
    CrossRef

  25. 25

    Felix G. Riepe, Miguel X. P. van Bemmelen, Francois Cachat, Hansjörg Plendl, Ivan Gautschi, Nils Krone, Paul-Martin Holterhus, Gerald Theintz, Laurent Schild. (2009) Revealing a subclinical salt-losing phenotype in heterozygous carriers of the novel S562P mutation in the α subunit of the epithelial sodium channel. Clinical Endocrinology 70:2, 252-258
    CrossRef

  26. 26

    Carlos Milla. 2009. Pulmonary Manifestations of Endocrine and Metabolic Diseases. , 170-183.
    CrossRef

  27. 27

    Christoph Korbmacher. (2009) Proteolytic activation of the epithelial sodium channel (ENaC) in health and disease. The Journal of Medical Investigation 56:Supplement, 306-307
    CrossRef

  28. 28

    Eun Jin Son, Sung Hunh Kim, Hun Yi Park, Su Jin Kim, Joo-Heon Yoon, Hyun Pil Chung, Jae Young Choi. (2009) Activation of epithelial sodium channel in human middle ear epithelial cells by dexamethasone. European Journal of Pharmacology 602:2-3, 383-387
    CrossRef

  29. 29

    K J Coote, H Atherton, A Young, R Sugar, R Burrows, N J Smith, J-M Schlaeppi, P J Groot-Kormelink, M Gosling, H Danahay. (2008) The guinea-pig tracheal potential difference as an in vivo model for the study of epithelial sodium channel function in the airways. British Journal of Pharmacology 155:7, 1025-1033
    CrossRef

  30. 30

    Aaron Hanukoglu, Oded Edelheit, Yafit Shriki, Maria Gizewska, Nathan Dascal, Israel Hanukoglu. (2008) Renin–aldosterone response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes. The Journal of Steroid Biochemistry and Molecular Biology 111:3-5, 268-274
    CrossRef

  31. 31

    WALTER L. MILLER, JOHN C. ACHERMANN, CHRISTA E. FLÜCK. 2008. The Adrenal Cortex and Its Disorders. , 444-511.
    CrossRef

  32. 32

    Marion Viel, Chrystel Leroy, Dominique Hubert, Isabelle Fajac, Thierry Bienvenu. (2008) ENaCβ and γ genes as modifier genes in cystic fibrosis. Journal of Cystic Fibrosis 7:1, 23-29
    CrossRef

  33. 33

    A M Woollhead, J Sivagnanasundaram, K K Kalsi, V Pucovsky, L J Pellatt, J W Scott, K J Mustard, D G Hardie, D L Baines. (2007) Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells. British Journal of Pharmacology 151:8, 1204-1215
    CrossRef

  34. 34

    Felix G Riepe. (2007) Molecular pathogenesis of renal pseudohypoaldosteronism type 1. Expert Review of Endocrinology & Metabolism 2:3, 407-419
    CrossRef

  35. 35

    Matthias Salathe. (2007) Regulation of Mammalian Ciliary Beating. Annual Review of Physiology 69:1, 401-422
    CrossRef

  36. 36

    H ARGOUBI, C FITCHNER, O RICHARD, M LAVOCAT, F CAMBAZARD, J STEPHAN. (2007) Miliaire rouge et pseudo hypoaldostéronémisme de type 1b de révélation néonatale. Annales de Dermatologie et de Vénéréologie 134:3, 253-256
    CrossRef

  37. 37

    D. J. Lubkin, E. A. Gaffney, J. R. Blake. (2007) A Viscoelastic Traction Layer Model of Muco-Ciliary Transport. Bulletin of Mathematical Biology 69:1, 289-327
    CrossRef

  38. 38

    Xiao Hu, Charles W. Bolten. (2006) Adrenal corticosteroids, their receptors and hypertension. Drug Development Research 67:12, 871-883
    CrossRef

  39. 39

    Kevin M. O'Shaughnessy, Fiona E. Karet. (2006) Salt Handling and Hypertension. Annual Review of Nutrition 26:1, 343-365
    CrossRef

  40. 40

    Frauke Stanke, Tim Becker, Harry Cuppens, Vinod Kumar, Jean-Jacques Cassiman, Silke Jansen, Dragica Radojkovic, Benny Siebert, Jennifer Yarden, David W. Ussery, Thomas F. Wienker, Burkhard Tümmler. (2006) The TNFα receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis. Human Genetics 119:3, 331-343
    CrossRef

  41. 41

    Jae Young Choi, Eun Jin Son, Jung Lim Kim, Joo-Hyeung Lee, Hun Yi Park, Sung Huhn Kim, Mee Hyun Song, Joo-Heon Yoon. (2006) ENaC- and CFTR-dependent ion and fluid transport in human middle ear epithelial cells. Hearing Research 211:1-2, 26-32
    CrossRef

  42. 42

    Z. Farfel, H. Mayan, Y. Yaacov, M. Mouallem, M. Shaharabany, R. Pauzner, E. Kerem, M. Wilschanski. (2005) WNK4 regulates Na+ transport in airways. European Journal of Clinical Investigation 35:6, 410-415
    CrossRef

  43. 43

    David S. Geller. (2005) Mineralocorticoid resistance. Clinical Endocrinology 62:5, 513-520
    CrossRef

  44. 44

    Oded Edelheit, Israel Hanukoglu, Maria Gizewska, Nurgun Kandemir, Yardena Tenenbaum-Rakover, Murat Yurdakok, Stanislaw Zajaczek, Aaron Hanukoglu. (2005) Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism. Clinical Endocrinology 62:5, 547-553
    CrossRef

  45. 45

    Mikko HALLMAN. (2005) Delayed clearance of fetal lung liquid and sodium transport-genetic predisposition not evident yet. Acta Paediatrica 94:3, 258-260
    CrossRef

  46. 46

    E. LANDMANN, M. SCHMIDTPOTT, E. TUTDIBI, L. GORTNER. (2005) Is transient tachypnoea of the newborn associated with polymorphisms in the epithelial sodium channel encoding gene? Investigation of the second transmembrane spanning domain of the α subunit. Acta Paediatrica 94:3, 317-323
    CrossRef

  47. 47

    M.M. Reddy, X.F. Wang, M. Gottschalk, K. Jones, P.M. Quinton. (2005) Normal CFTR Activity and Reversed Skin Potentials in Pseudohypoaldosteronism. Journal of Membrane Biology 203:3, 151-159
    CrossRef

  48. 48

    Mikko Hallman. (2005) Delayed clearance of fetal lung liquid and sodium transport—genetic predisposition not evident yet. Acta Paediatrica 94:3, 258
    CrossRef

  49. 49

    Harald H. Kessler, Evelyn Stelzl, Alexander C. Haushofer. 2004. Lamivudine Resistance‐Associated Gene Mutations. , 700-702.
    CrossRef

  50. 50

    M. Eisenhut, D. Sidaras, P. Barton, P. Newland, K. W. Southern. (2004) Elevated sweat sodium associated with pulmonary oedema in meningococcal sepsis. European Journal of Clinical Investigation 34:8, 576-579
    CrossRef

  51. 51

    Kevin M. O’Shaughnessy, Fiona E. Karet. (2004) Salt handling and hypertension. Journal of Clinical Investigation 113:8, 1075-1081
    CrossRef

  52. 52

    Richard E. Olver, Dafydd V. Walters, Stuart M. Wilson. (2004) Developmental Regulation of Lung Liquid Transport. Annual Review of Physiology 66:1, 77-101
    CrossRef

  53. 53

    David G Warnock. (2003) Hereditary disorders of potassium homeostasis. Best Practice & Research Clinical Endocrinology & Metabolism 17:4, 505-527
    CrossRef

  54. 54

    (2002) Variant Cystic Fibrosis Phenotypes in the Absence of CFTR Mutations. New England Journal of Medicine 347:23, 1892-1893
    Full Text

  55. 55

    R.C Boucher. (2002) An overview of the pathogenesis of cystic fibrosis lung disease. Advanced Drug Delivery Reviews 54:11, 1359-1371
    CrossRef

  56. 56

    Andrew J Hirsh. (2002) Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents. Advanced Drug Delivery Reviews 54:11, 1445-1462
    CrossRef

  57. 57

    Enzo Ottaviani, Antonella Franchini, Mauro Mandrioli, Anjana Saxena, Aaron Hanukoglu, Israel Hanukoglu. (2002) Amiloride-sensitive epithelial sodium channel subunits are expressed in human and mussel immunocytes. Developmental & Comparative Immunology 26:5, 395-402
    CrossRef

  58. 58

    Sartori, Claudio, Allemann, Yves, Duplain, Hervé, Lepori, Mattia, Egli, Marc, Lipp, Ernst, Hutter, Damian, Turini, Pierre, Hugli, Olivier, Cook, Stéphane, Nicod, Pascal, Scherrer, Urs, . (2002) Salmeterol for the Prevention of High-Altitude Pulmonary Edema. New England Journal of Medicine 346:21, 1631-1636
    Full Text

  59. 59

    Tzvy Bistritzer, Eitan Kerem, Matitiahu Berkovitch, Micha J. Rapoport, Sandra Evans, Mordechai Aladjem. (2002) Erythrocyte Na+,K+-ATPase and nasal potential in pseudohypoaldosteronism*. Clinical Endocrinology 56:5, 575-580
    CrossRef

  60. 60

    Peter J. Fuller, Fraser M. Rogerson. (2002) Pseudohypoaldosteronism: kidney, lungs and colon*. Clinical Endocrinology 56:5, 571-572
    CrossRef

  61. 61

    Eric Delpire, David B. Mount. (2002) H UMAN AND M URINE P HENOTYPES A SSOCIATED WITH D EFECTS IN C ATION -C HLORIDE C OTRANSPORT. Annual Review of Physiology 64:1, 803-843
    CrossRef

  62. 62

    Michael R. Knowles, Richard C. Boucher. (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. Journal of Clinical Investigation 109:5, 571-577
    CrossRef

  63. 63

    David G. Warnock. (2002) R ENAL G ENETIC D ISORDERS R ELATED TO K + AND Mg 2+. Annual Review of Physiology 64:1, 845-876
    CrossRef

  64. 64

    Bernard C. Rossier, Sylvain Pradervand, Laurent Schild, Edith Hummler. (2002) E PITHELIAL S ODIUM C HANNEL AND THE C ONTROL OF S ODIUM B ALANCE : Interaction Between Genetic and Environmental Factors. Annual Review of Physiology 64:1, 877-897
    CrossRef

  65. 65

    M Eisenhut, KW Southern. (2002) Positive sweat test following meningococcal septicaemia. Acta Paediatrica 91:3, 361-362
    CrossRef

  66. 66

    Aaron Hanukoglu, Olga Belutserkovsky, Moshe Phillip. (2001) Growth hormone activates renin–aldosterone system in children with idiopathic short stature and in a pseudohypoaldosteronism patient with a mutation in epithelial sodium channel alpha subunit. The Journal of Steroid Biochemistry and Molecular Biology 77:1, 49-57
    CrossRef

  67. 67

    Richard P. Lifton, Ali G. Gharavi, David S. Geller. (2001) Molecular Mechanisms of Human Hypertension. Cell 104:4, 545-556
    CrossRef

  68. 68

    Daniela Rotin. (2000) Regulation of the epithelial sodium channel (ENaC) by accessory proteins. Current Opinion in Nephrology and Hypertension 9:5, 529-534
    CrossRef

  69. 69

    Michael A. Matthay, Norimasa Fukuda, James Frank, Richard Kallet, Brian Daniel, Tsutomu Sakuma. (2000) ALVEOLAR EPITHELIAL BARRIER. Clinics in Chest Medicine 21:3, 477-490
    CrossRef

  70. 70

    Olivier Bonny, Edith Hummler. (2000) Dysfunction of epithelial sodium transport: From human to mouse. Kidney International 57:4, 1313-1318
    CrossRef

  71. 71

    Stefan Gründer. 2000. Liddle's syndrome and pseudohypoaldosteronism type I. , 277-297.
    CrossRef